Evolution of the average Target Price on ROCHE HOLDING AG |
|
|
Target Price consensus revisions : last 18 months |
|
|
Recommendations (Chart) ROCHE HOLDING AG |
|
|
Analyst Recommendations on ROCHE HOLDING AG |
|
|
| |
|
|
Regeneron's COVID drug sales outside U.S. help revenue beat |
|
Mean consensus |
OUTPERFORM |
Number of Analysts |
24 |
Last Close Price |
319,70 CHF |
Average target price |
396,90 CHF |
Spread / Average Target |
24,1% |
High Price Target |
475,80 CHF |
Spread / Highest target |
48,8% |
Low Price Target |
330,00 CHF |
Spread / Lowest Target |
3,22% |
Consensus revision (last 18 months)
|